GlassScriptPhysician profile
Bruce A Piszel
NPI 1467553966
$3,148.37
in general payments reported to CMS, 2019-2025
20 companies · $920 in 2025
The $920 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $71.58 · 2021: $77.77 · 2022: $266 · 2023: $367 · 2024: $1,188 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,854 · Travel and Lodging: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,853.64 |
| Travel and Lodging | $622.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,579.04 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Nalu Medical, INC. | $860.26 | 2024-2025 | Nalu Neurostimulation System |
| Painteq LLC | $99.00 | 2023-2024 | Painteq |
| Astrazeneca Pharmaceuticals LP | $88.87 | 2019-2020 | |
| Spinal Simplicity, LLC | $68.90 | 2025 | Ha Minuteman G3-R |
| Abbvie INC. | $67.51 | 2024-2025 | |
| Amgen INC. | $56.69 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $55.68 | 2025 | |
| Valinor Pharma, LLC | $40.88 | 2025 | Movantik |
| Pfizer INC. | $36.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.66 | 2019 | |
| Biotronik Nro, INC. | $29.97 | 2025 | Prospera |
| Si-Bone, INC. | $24.03 | 2025 | |
| Medtronic USA, INC. | $22.57 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.47 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.63 | 2025 | Eterna |
| Scilex Pharmaceuticals INC. | $15.25 | 2019 | |
| Vertos Medical, INC. | $14.91 | 2020 | |
| Kaleo, INC. | $11.52 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Piszel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.